source
- Kolon TissueGene cuts 37 jobs after phase 3 osteoarthritis trial failsKolon TissueGene announced it will lay off 37 employees at its Maryland headquarters, with the reductions set to take effect at the end of August. The cuts follow a phase 3 trial of the company’s…
- Municipalities and States Grapple with Rising Health-Insurance Costs and Upcoming Medicaid Drug Pricing DeadlineMunicipalities across the country are reporting that the cost of providing health insurance to their employees is becoming increasingly unsustainable, putting pressure on local budgets. States are…